Concord Medical Services Holdings Limited
Symbol: CCM
NYSE
0.52
USDTržní cena dnes
-0.9214
Poměr P/E
0.0139
Poměr PEG
14.64M
MRK Cap
- 0.00%
Výnos DIV
Concord Medical Services Holdings Limited (CCM) finanční výkazy
Rozvaha
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 58.1 | 158.3 | 157.4 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.net-receivables | 0 | 73.5 | 512.8 | 383 | ||||||||||||||||
balance-sheet.row.inventory | 0 | 40.3 | 84.8 | 38.1 | ||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 412.9 | 24.3 | 6 | ||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 617.2 | 759.8 | 584.5 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 3734 | 3446.6 | 3347.7 | ||||||||||||||||
balance-sheet.row.goodwill | 0 | 575.4 | 575.4 | 581.9 | ||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 721.1 | 762.1 | 1074.7 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1296.6 | 1337.5 | 1656.6 | ||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 394.7 | 437.9 | 390.6 | ||||||||||||||||
balance-sheet.row.tax-assets | 0 | 5.1 | 0 | 237 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 6.3 | 23.2 | 13.6 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 5436.7 | 5245.1 | 5645.5 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 0 | 6053.9 | 6004.9 | 6230 | ||||||||||||||||
balance-sheet.row.account-payables | 0 | 129.2 | 146.7 | 102.5 | ||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 1088.7 | 548.5 | 319.8 | ||||||||||||||||
balance-sheet.row.tax-payables | 0 | 17.1 | 28.8 | 21 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 2207 | 2691.4 | 2412.8 | ||||||||||||||||
Deferred Revenue Non Current | 0 | 44.5 | 0 | 81.2 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 674.1 | 325.2 | 301.1 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 2355.6 | 2868 | 2681.7 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 239.5 | 235.9 | 234.7 | ||||||||||||||||
balance-sheet.row.total-liab | 0 | 4307 | 3989.3 | 3486.2 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | ||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -4064.6 | -3766.9 | -3277.3 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -65.4 | -27.8 | -29.5 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2008 | 1930.6 | 1936.5 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | -2121.9 | -1864 | -1370.1 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 6053.9 | 6004.9 | 6230 | ||||||||||||||||
balance-sheet.row.minority-interest | 0 | 3868.9 | 3879.6 | 4113.8 | ||||||||||||||||
balance-sheet.row.total-equity | 0 | 1747 | 2015.7 | 2743.7 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||
Total Investments | 0 | 394.7 | 437.9 | 390.6 | ||||||||||||||||
balance-sheet.row.total-debt | 0 | 3295.7 | 3239.9 | 2732.7 | ||||||||||||||||
balance-sheet.row.net-debt | 0 | 3237.6 | 3081.6 | 2575.3 |
Výkaz peněžních toků
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -769 | -522.7 | -404 | |||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 132.8 | 104.1 | 80.3 | |||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -71.8 | 11.3 | -13.3 | |||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -5.9 | 14.7 | 20.6 | |||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 105 | -46.6 | -32.6 | |||||||||||||||
cash-flows.row.account-receivables | 0 | 0.6 | -64.5 | -6.2 | |||||||||||||||
cash-flows.row.inventory | 0 | -46.8 | -4.4 | -14.4 | |||||||||||||||
cash-flows.row.account-payables | 0 | 113.7 | 262.8 | 11.1 | |||||||||||||||
cash-flows.row.other-working-capital | 0 | 37.4 | -240.6 | -23.1 | |||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 392.2 | 79.9 | 119.3 | |||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -384.8 | -780.3 | -512.9 | |||||||||||||||
cash-flows.row.acquisitions-net | 0 | -2.3 | -66 | 62.4 | |||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 209.1 | -108.5 | |||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 11.9 | 20 | -7.9 | |||||||||||||||
cash-flows.row.other-investing-activites | 0 | 256.4 | 51.2 | 33 | |||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -118.8 | -566 | -533.9 | |||||||||||||||
cash-flows.row.debt-repayment | 0 | -394.6 | -230.8 | -1271 | |||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.other-financing-activites | 0 | 777.7 | 873.2 | 2409.3 | |||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 383.1 | 642.4 | 1138.3 | |||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -47.2 | -4.6 | -2.6 | |||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 0.4 | -287.5 | 372.1 | |||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 159.3 | 158.9 | 446.4 | |||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 158.9 | 446.4 | 74.3 | |||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -216.7 | -359.3 | -229.8 | |||||||||||||||
cash-flows.row.capital-expenditure | 0 | -384.8 | -780.3 | -512.9 | |||||||||||||||
cash-flows.row.free-cash-flow | 0 | -601.5 | -1139.6 | -742.7 |
Řádek výkazu zisku a ztráty
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 537.4 | 472.1 | 485.6 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 614 | 624.5 | 542.5 | ||||||||||||||||
income-statement-row.row.gross-profit | 0 | -76.6 | -152.4 | -56.9 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | 0 | -10.8 | -216.6 | -1.2 | ||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 386.4 | 372.6 | 401.4 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1000.4 | 997.1 | 944 | ||||||||||||||||
income-statement-row.row.interest-income | 0 | 10.8 | 10 | 5.9 | ||||||||||||||||
income-statement-row.row.interest-expense | 0 | 165.7 | 120.4 | 73.8 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 62.2 | -314.8 | -70.9 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -10.8 | -216.6 | -1.2 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 62.2 | -314.8 | -70.9 | ||||||||||||||||
income-statement-row.row.interest-expense | 0 | 165.7 | 120.4 | 73.8 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 128.5 | -56.1 | 126.9 | ||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | 0 | -463 | -525 | -458.3 | ||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -555.6 | -839.9 | -529.2 | ||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | -24.6 | -70.9 | -6.6 | ||||||||||||||||
income-statement-row.row.net-income | 0 | -297.7 | -769 | -522.7 |
Často kladené otázky
Co je Concord Medical Services Holdings Limited (CCM) celková aktiva?
Concord Medical Services Holdings Limited (CCM) celková aktiva jsou 6053943000.000.
Jaký je roční obrat podniku?
Roční příjmy jsou N/A.
Jaké je ziskové rozpětí podniku?
Zisková marže firmy je -0.142.
Jaký je volný peněžní tok podniku?
Volný peněžní tok je -26.194.
Jaká je čistá zisková marže podniku?
Čistá zisková marže je -0.553.
Jaké jsou celkové tržby podniku?
Celkové příjmy jsou -0.861.
Co je Concord Medical Services Holdings Limited (CCM) čistý zisk (čistý příjem)?
Čistý zisk (čistý příjem) je -297658000.000.
Jaký je celkový dluh podniku?
Celkový dluh je 3295701000.000.
Jaké je číslo provozních nákladů?
Provozní výdaje jsou 386377000.000.
Jaké je číslo peněžních prostředků firmy?
Peněžní prostředky podniku jsou 0.000.